CGC
CGC
NASDAQ · Pharmaceuticals

Canopy Growth Corp

$0.98
+0.05 (+5.28%)
As of Aug 8, 1:51 AM ET ·
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Buy 7 58%
Hold 5 42%
Sell 0 0%
Price Target
Analyst Price Target +2,294.5% upside
Low Target $17.63
Average Target $23.50
High Target $33.45
Current Price $0.98
Current
$0.98
Target
$23.50
$17.63 $23.50 avg $33.45
Scenario Analysis
Bear Case
$17.63
1,696.4%
Low target
Base Case
$23.50
+2,294.5%
Avg target
Bull Case
$33.45
+3,308.4%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.28
-70.1% from high
52-Week Low
$1.18
+-16.8% from low
Target vs 52W High
$23.50
+616.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%